The risk of drug-induced hepatitis and adverse effects with anti-tuberculosis drugs in active viral hepatitis patients with liver functional disorder was 2.11 times as much as latent viral hepatitis patients and the difference was also statistically significant (P=0.0297; RR=2.11; 95% CI: 0.158 - 0.844).